🇺🇸 FDA
Patent

US 10959984

Methods for treating cancer with RORγ inhibitors

granted A61KA61K31/18A61K31/185

Quick answer

US patent 10959984 (Methods for treating cancer with RORγ inhibitors) held by The Regents of the University of California expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/18, A61K31/185, A61K31/403, A61K31/4166